Abstract
SUMMARYTransmission of SARS-CoV-2 from humans to farmed mink was observed in Europe and the US. In the infected animals viral variants arose that harbored mutations in the spike (S) protein, the target of neutralizing antibodies, and these variants were transmitted back to humans. This raised concerns that mink might become a constant source of human infection with SARS-CoV-2 variants associated with an increased threat to human health and resulted in mass culling of mink. Here, we report that mutations frequently found in the S proteins of SARS-CoV-2 from mink were mostly compatible with efficient entry into human cells and its inhibition by soluble ACE2. In contrast, mutation Y453F reduced neutralization by an antibody with emergency use authorization for COVID-19 therapy and by sera/plasma from COVID-19 patients. These results suggest that antibody responses induced upon infection or certain antibodies used for treatment might offer insufficient protection against SARS-CoV-2 variants from mink.
Publisher
Cold Spring Harbor Laboratory
Reference47 articles.
1. (WHO), W.H.O. (2021). Weekly operational update on COVID-19 - 9 February 2020 (WHO).
2. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
3. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
4. Bazykin, G.A.S. , O.; Danilenko, D ; Fadeev, A ; Komissarova, K ; Ivanova, A ; Sergeeva, M. ; Safina, K ; Nabieva, E. ; Klink, G. ; Garushyants, S. ; Zabutova, J. ; Kholodnaia, A. ; Skorokhod, I. ; Ryabchikova, V.V. ; Komissarov, A. ; Lioznov, D. (2021). Emergence of Y453F and Δ69-70HV mutations in a lymphoma patient with long-term COVID-19
5. A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon